Krensavage Asset Management LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-27 1:11 pm Purchase | 2024-02-22 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Krensavage Asset Management LLC | 1,086,024 5.100% | 1,086,024 (New Position) | Filing |